“Tolerability and Efficacy of Apixaban Versus Rivaroxaban for Non-Valvular Atrial Fibrillation”. Medical Forum Monthly, vol. 33, no. 3, Apr. 2022, http://medicalforummonthly.com/index.php/mfm/article/view/586.